Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression

Xin Jin; Donglin Ding; Yuqian Yan; Hui Li; Bo Wang; Linlin Ma; Zhenqing Ye; Tao Ma; Qiang Wu; Daniel N. Rodrigues; Manish Kohli; Rafael Jimenez; Liguo Wang; David W. Goodrich; Johann de Bono; Haidong Dong; Heshui Wu; Runzhi Zhu; Haojie Huang

doi:10.1016/j.molcel.2018.10.034

Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression

Xin Jin
, Donglin Ding
, Yuqian Yan
, Hui Li
, Bo Wang
, Linlin Ma
, Zhenqing Ye
, Tao Ma
, Qiang Wu
, Daniel N. Rodrigues
, Manish Kohli
, Rafael Jimenez
, Liguo Wang
, David W. Goodrich
, Johann de Bono
, Haidong Dong
, Heshui Wu
, Runzhi Zhu
, Haojie Huang

Producción científica: Article › revisión exhaustiva

235 Citas (Scopus)

Resumen

RB is known to act as a tumor suppressor by inhibiting E2F transcription factors, and this function is abolished due to its phosphorylation by CDKs. Jin et al. identify a previously uncharacterized tumor suppressor role of CDK4/6-phosphorylated RB in promoting cancer immunity via inhibition of NF-κB transcriptional activity and PD-L1 expression.

Idioma original	English (US)
Páginas (desde-hasta)	22-35.e6
Publicación	Molecular Cell
Volumen	73
N.º	1
DOI	https://doi.org/10.1016/j.molcel.2018.10.034
Estado	Published - ene 3 2019
Publicado de forma externa	Sí

ASJC Scopus subject areas

Molecular Biology
Cell Biology

Acceder al documento

10.1016/j.molcel.2018.10.034

Otros archivos y enlaces

Citar esto

Jin, X., Ding, D., Yan, Y., Li, H., Wang, B., Ma, L., Ye, Z., Ma, T., Wu, Q., Rodrigues, D. N., Kohli, M., Jimenez, R., Wang, L., Goodrich, D. W., de Bono, J., Dong, H., Wu, H., Zhu, R., & Huang, H. (2019). Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression. Molecular Cell, 73(1), 22-35.e6. https://doi.org/10.1016/j.molcel.2018.10.034

Jin, X, Ding, D, Yan, Y, Li, H, Wang, B, Ma, L, Ye, Z, Ma, T, Wu, Q, Rodrigues, DN, Kohli, M, Jimenez, R, Wang, L, Goodrich, DW, de Bono, J, Dong, H, Wu, H, Zhu, R & Huang, H 2019, 'Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression', Molecular Cell, vol. 73, n.º 1, pp. 22-35.e6. https://doi.org/10.1016/j.molcel.2018.10.034

@article{9ffab7446d8c4c07875ffb8c1a923afa,

title = "Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression",

abstract = "RB is known to act as a tumor suppressor by inhibiting E2F transcription factors, and this function is abolished due to its phosphorylation by CDKs. Jin et al. identify a previously uncharacterized tumor suppressor role of CDK4/6-phosphorylated RB in promoting cancer immunity via inhibition of NF-κB transcriptional activity and PD-L1 expression.",

keywords = "CDK4/6 inhibitor, CHD1, MAP3K7, NF-κB, PD-L1, RB, immunotherapy, phosphorylation, prostate cancer, radiotherapy",

author = "Xin Jin and Donglin Ding and Yuqian Yan and Hui Li and Bo Wang and Linlin Ma and Zhenqing Ye and Tao Ma and Qiang Wu and Rodrigues, \{Daniel N.\} and Manish Kohli and Rafael Jimenez and Liguo Wang and Goodrich, \{David W.\} and \{de Bono\}, Johann and Haidong Dong and Heshui Wu and Runzhi Zhu and Haojie Huang",

note = "Publisher Copyright: {\textcopyright} 2018 Elsevier Inc.",

year = "2019",

month = jan,

day = "3",

doi = "10.1016/j.molcel.2018.10.034",

language = "English (US)",

volume = "73",

pages = "22--35.e6",

journal = "Molecular Cell",

issn = "1097-2765",

publisher = "Cell Press",

number = "1",

}

TY - JOUR

T1 - Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression

AU - Jin, Xin

AU - Ding, Donglin

AU - Yan, Yuqian

AU - Li, Hui

AU - Wang, Bo

AU - Ma, Linlin

AU - Ye, Zhenqing

AU - Ma, Tao

AU - Wu, Qiang

AU - Rodrigues, Daniel N.

AU - Kohli, Manish

AU - Jimenez, Rafael

AU - Wang, Liguo

AU - Goodrich, David W.

AU - de Bono, Johann

AU - Dong, Haidong

AU - Wu, Heshui

AU - Zhu, Runzhi

AU - Huang, Haojie

PY - 2019/1/3

Y1 - 2019/1/3

N2 - RB is known to act as a tumor suppressor by inhibiting E2F transcription factors, and this function is abolished due to its phosphorylation by CDKs. Jin et al. identify a previously uncharacterized tumor suppressor role of CDK4/6-phosphorylated RB in promoting cancer immunity via inhibition of NF-κB transcriptional activity and PD-L1 expression.

AB - RB is known to act as a tumor suppressor by inhibiting E2F transcription factors, and this function is abolished due to its phosphorylation by CDKs. Jin et al. identify a previously uncharacterized tumor suppressor role of CDK4/6-phosphorylated RB in promoting cancer immunity via inhibition of NF-κB transcriptional activity and PD-L1 expression.

KW - CDK4/6 inhibitor

KW - CHD1

KW - MAP3K7

KW - NF-κB

KW - PD-L1

KW - RB

KW - immunotherapy

KW - phosphorylation

KW - prostate cancer

KW - radiotherapy

UR - https://www.scopus.com/pages/publications/85059121899

UR - https://www.scopus.com/pages/publications/85059121899#tab=citedBy

U2 - 10.1016/j.molcel.2018.10.034

DO - 10.1016/j.molcel.2018.10.034

M3 - Article

C2 - 30527665

AN - SCOPUS:85059121899

SN - 1097-2765

VL - 73

SP - 22-35.e6

JO - Molecular Cell

JF - Molecular Cell

IS - 1

ER -

Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression

Resumen

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto